Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Andrew M. Overmiller, Kathleen P. McGuinn, Brett J. Roberts, Felicia Cooper, Donna M. Brennan-Crispi, Takahiro Deguchi, Sirkku Peltonen, James K. Wahl III, Mỹ G. Mahoney
Published Feb 24, 2016 · Vol. 7, No. 25 · pp. 37536-37555
Francesco Passiglia, Giuseppe Bronte, Viviana Bazan, Clara Natoli, Sergio Rizzo, Antonio Galvano, Angela Listì, Giuseppe Cicero, Christian Rolfo, Daniele Santini, Antonio Russo
Published Feb 22, 2016 · Vol. 7, No. 15 · pp. 19738-19747
Maria J. De Herdt, Stefan M. Willems, Berdine van der Steen, Rob Noorlag, Esther I. Verhoef, Geert J.L.H. van Leenders, Robert J.J. van Es, Senada Koljenović, Robert J. Baatenburg de Jong, Leendert H.J. Looijenga
Published Feb 20, 2016 · Vol. 7, No. 11 · pp. 13167-13181